Simplex Trading, LLC Regulus Therapeutics Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$1.79 - $2.8 $128,572 - $201,118	-71,828 Reduced 95.2%	3,622 $6,000
Q1 2024 Apr 25, 2024	BUY	$1.13 - $2.88 $85,258 - $217,296	75,450 New	75,450 $217,000
Q4 2022 Feb 02, 2023	BUY	$1.17 - $1.85 $352 - $556	301 New	301 $0
Q2 2022 Aug 03, 2022	BUY	$1.6 - $3.4 $843 - $1,791	527 New	527 $1,000

56.5M

79.3K

20.3K

Ticker RGLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,634,400
Market Cap $24M
Description
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.